Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Trevi Therapeutics, Inc. (TRVI)
USD16.52
-1.32 (-7.40%)
US NASDAQ Healthcare Biotechnology
Address
195 Church Street 6510
New Haven, CT, US
New Haven, CT, US
CEO
Jennifer L. Good
Website
trevitherapeutics.com
IPO
2019-05-07
CIK 1563880 ISIN US89532M1018
Description
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the advancement and commercialization of Haduvio, a potential treatment for debilitating neurologically mediated conditions. This orally administered, extended-release formulation of nalbuphine is currently undergoing Phase IIb/III clinical trials for chronic pruritus (severe itching) and persistent cough experienced by patients with idiopathic pulmonary fibrosis. Trevi Therapeutics also possesses a licensing agreement with Endo Pharmaceuticals Inc., granting it the rights to develop and market products containing nalbuphine hydrochloride in various formulations. Established in 2011, the company maintains its corporate headquarters in New Haven, Connecticut.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD16.52
-1.32 (-7.40%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.05
Float Shares
105.98M
Free Float %
74.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.62% | +4.64% | +12.81% | +36.01% | +25.57% | +18.85% | +122.09% | +425.80% | +592.09% | +88.59% | +88.59% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (17 ratings, all time)
Buy
Price Targets & DCF
Current price
16.52
Low
16.00
-3.1%
Consensus
22.50
+36.2%
Median
22.00
+33.2%
High
30.00
+81.6%
DCF (Unlevered)
0.11
-99.4%
DCF (Levered)
0.13
-99.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 9 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 4 |
19.25
+16.5%
|
| All Time | 7 |
14.43
-12.7%
|
Quality scores
Altman Z-Score
162.74
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+38.3% ★ Q1'26: -3.1% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: -5,804.8% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+43.6% Q1'26: +23.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.02× Q1'26: -0.01× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 10 Rev. Ana. 6 EPS Ana. |
Dec 2027 6 Rev. Ana. 8 EPS Ana. |
Dec 2028 7 Rev. Ana. 9 EPS Ana. |
Dec 2029 3 Rev. Ana. 3 EPS Ana. |
Dec 2030 6 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
|
1.10M
1.10M – 1.10M
|
3.47M
3.47M – 3.47M
+215.8% YoY
|
31.87M
31.87M – 31.87M
+819.3% YoY
|
141.59M
141.59M – 141.59M
+344.3% YoY
|
417.03M
417.03M – 417.03M
+194.5% YoY
|
| EBITDA |
-47.79M
|
-42.68M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-47.94M
|
-42.82M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-47.91M
est: -50.73M (+5.6%)
|
-42.76M
est: -52.11M (+18.0%)
|
-79.75M
-81.35M – -42.13M
-53.0% YoY
|
-98.24M
-132.40M – -51.81M
-23.2% YoY
|
-91.42M
-172.66M – 155.25M
+6.9% YoY
|
-40.19M
-40.19M – -40.19M
+56.0% YoY
|
129.47M
129.47M – 129.47M
+422.1% YoY
|
| SGA |
12.15M
|
15.85M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-0.47
est: -0.51 (+7.3%)
|
-0.29
est: -0.36 (+20.4%)
|
-0.45
-0.56 – -0.29
-23.7% YoY
|
-0.56
-0.91 – -0.36
-23.3% YoY
|
-0.54
-1.19 – 1.07
+3.0% YoY
|
-0.28
-0.28 – -0.28
+48.6% YoY
|
0.89
0.89 – 0.89
+422.1% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-17 | D. Boral Capital | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
26
Total invested
33.96M
Insider transactions (90d)
0
Beneficial owners (>5%)
50
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 16 GP, LLC | 15.07M | 18.70% | — | 15.07M | — | 15.07M | OO | Delaware | 2024-11-08 | ↗ |
| 2 | A. Florence, Jr. | 15.07M | 18.70% | — | 15.07M | — | 15.07M | IN | States | 2024-11-08 | ↗ |
| 3 | Behbahani | 15.07M | 18.70% | — | 15.07M | — | 15.07M | IN | States | 2024-11-08 | ↗ |
| 4 | Chang | 15.07M | 18.70% | — | 15.07M | — | 15.07M | IN | States | 2024-11-08 | ↗ |
| 5 | D. Sandell | 15.07M | 18.70% | — | 15.07M | — | 15.07M | IN | States | 2024-11-08 | ↗ |
| 6 | Enterprise Associates 16, L.P. | 15.07M | 18.70% | — | 15.07M | — | 15.07M | PN | Delaware | 2024-11-08 | ↗ |
| 7 | H. Makhzoumi | 15.07M | 18.70% | — | 15.07M | — | 15.07M | IN | States | 2024-11-08 | ↗ |
| 8 | NEA 18 VGE GP, LLC | 15.07M | 18.70% | — | 15.07M | — | 15.07M | OO | Delaware | 2024-11-08 | ↗ |
| 9 | NEA 18 Venture Growth Equity, L.P. | 15.07M | 18.70% | — | 15.07M | — | 15.07M | PN | Delaware | 2024-11-08 | ↗ |
| 10 | NEA Partners 18 VGE, L.P. | 15.07M | 18.70% | — | 15.07M | — | 15.07M | PN | Delaware | 2024-11-08 | ↗ |
| 11 | Partners 16, L.P. | 15.07M | 18.70% | — | 15.07M | — | 15.07M | PN | Delaware | 2024-11-08 | ↗ |
| 12 | Walker | 15.07M | 18.70% | — | 15.07M | — | 15.07M | IN | States | 2024-11-08 | ↗ |
| 13 | Baskett | 14.13M | 17.50% | — | 14.13M | — | 14.13M | IN | States | 2024-11-08 | ↗ |
| 14 | David C. Ott | 5.98M | 9.99% | — | 5.98M | — | 5.98M | IN | Delaware | 2022-10-07 | ↗ |
| 15 | O. Andreas Halvorsen | 5.98M | 9.99% | — | 5.98M | — | 5.98M | IN | Delaware | 2022-10-07 | ↗ |
| 16 | Rose S. Shabet | 5.98M | 9.99% | — | 5.98M | — | 5.98M | IN | Delaware | 2022-10-07 | ↗ |
| 17 | Viking Global Investors LP | 5.98M | 9.99% | — | 5.98M | — | 5.98M | PN | Delaware | 2022-10-07 | ↗ |
| 18 | Viking Global Opportunities Parent GP LLC | 5.98M | 9.99% | — | 5.98M | — | 5.98M | OO | Delaware | 2022-10-07 | ↗ |
| 19 | David Rosen | 5.68M | 9.49% | — | 5.68M | — | — | IN | United States of America | 2023-02-10 | ↗ |
| 20 | LP | 5.68M | 9.49% | — | 5.68M | — | — | IA, PN | State of Delaware | 2023-02-10 | ↗ |
| 21 | Viking Global Opportunities GP LLC | 4.01M | 6.69% | — | 4.01M | — | 4.01M | OO | Delaware | 2022-10-07 | ↗ |
| 22 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 4.01M | 6.69% | — | 4.01M | — | 4.01M | PN | Delaware | 2022-10-07 | ↗ |
| 23 | Viking Global Opportunities Portfolio GP LLC | 4.01M | 6.69% | — | 4.01M | — | 4.01M | OO | Delaware | 2022-10-07 | ↗ |
| 24 | Patrick J. Heron | 3.82M | 10.00% | — | 3.82M | — | 3.82M | IN | Delaware | 2022-04-18 | ↗ |
| 25 | Fairmount Funds Management LLC | 3.76M | 9.90% | — | 3.76M | — | 3.76M | IA | Delaware | 2022-04-21 | ↗ |
| 26 | Fairmount Healthcare Fund II L.P. | 3.76M | 9.90% | — | 3.76M | — | 3.76M | PN | Delaware | 2022-04-21 | ↗ |
| 27 | Peter Harwin | 3.76M | 9.90% | — | 3.76M | — | 3.76M | HC, IN | United States | 2022-04-21 | ↗ |
| 28 | Tomas Kiselak | 3.76M | 9.90% | — | 3.76M | — | 3.76M | HC, IN | Slovak Republic | 2022-04-21 | ↗ |
| 29 | Koh, Bong | 3.67M | 9.99% | — | 3.67M | — | 3.67M | IN | United States | 2022-04-21 | ↗ |
| 30 | Shah, Nimish | 3.67M | 9.99% | — | 3.67M | — | 3.67M | IN | United States | 2022-04-21 | ↗ |
| 31 | VHCP Co-Investment Holdings II, LLC | 3.67M | 9.99% | — | 3.67M | — | 3.67M | OO | Delaware | 2022-04-21 | ↗ |
| 32 | VHCP Co-Investment Holdings III, LLC | 3.67M | 9.99% | — | 3.67M | — | 3.67M | OO | Delaware | 2022-04-21 | ↗ |
| 33 | VHCP Management EG, LLC | 3.67M | 9.99% | — | 3.67M | — | 3.67M | OO | Delaware | 2022-04-21 | ↗ |
| 34 | VHCP Management II, LLC | 3.67M | 9.99% | — | 3.67M | — | 3.67M | OO | Delaware | 2022-04-21 | ↗ |
| 35 | VHCP Management III, LLC | 3.67M | 9.99% | — | 3.67M | — | 3.67M | OO | Delaware | 2022-04-21 | ↗ |
| 36 | Venrock Healthcare Capital Partners EG, L.P. | 3.67M | 9.99% | — | 3.67M | — | 3.67M | PN | Delaware | 2022-04-21 | ↗ |
| 37 | Venrock Healthcare Capital Partners II, L.P. | 3.67M | 9.99% | — | 3.67M | — | 3.67M | PN | Delaware | 2022-04-21 | ↗ |
| 38 | Venrock Healthcare Capital Partners III, L.P. | 3.67M | 9.99% | — | 3.67M | — | 3.67M | PN | Delaware | 2022-04-21 | ↗ |
| 39 | Albert Cha | 2.61M | 7.00% | — | 2.61M | — | 2.61M | IN | Delaware | 2022-04-18 | ↗ |
| 40 | Gilad Aharon | 2.50M | 4.20% | — | 2.50M | — | 2.50M | IN | ONTARIO, CANADA | 2023-02-15 | ↗ |
| 41 | Rosalind Master Fund L.P. | 2.50M | 4.20% | — | 2.50M | — | 2.50M | PN | CAYMAN ISLANDS | 2023-02-15 | ↗ |
| 42 | Steven Salamon | 2.50M | 4.20% | — | 2.50M | — | 2.50M | IN | ONTARIO, CANADA | 2023-02-15 | ↗ |
| 43 | Viking Global Opportunities Drawdown (Aggregator) LP | 1.97M | 3.30% | — | 1.97M | — | 1.97M | OO | Delaware | 2022-10-07 | ↗ |
| 44 | Viking Global Opportunities Drawdown GP LLC | 1.97M | 3.30% | — | 1.97M | — | 1.97M | OO | Delaware | 2022-10-07 | ↗ |
| 45 | Viking Global Opportunities Drawdown Portfolio GP LLC | 1.97M | 3.30% | — | 1.97M | — | 1.97M | OO | Delaware | 2022-10-07 | ↗ |
| 46 | FHMLS XI, L.L.C. | 622.1K | 1.70% | — | 622.1K | — | 622.1K | OO | Delaware | 2022-04-18 | ↗ |
| 47 | FHMLS XI, L.P. | 622.1K | 1.70% | — | 622.1K | — | 622.1K | PN | Delaware | 2022-04-18 | ↗ |
| 48 | Frazier Life Sciences XI, L.P. | 622.1K | 1.70% | — | 622.1K | — | 622.1K | PN | Delaware | 2022-04-18 | ↗ |
| 49 | FHMLS X, L.L.C. | 583.9K | 1.60% | — | 583.9K | — | 583.9K | OO | Delaware | 2022-04-18 | ↗ |
| 50 | FHMLS X, L.P. | 583.9K | 1.60% | — | 583.9K | — | 583.9K | PN | Delaware | 2022-04-18 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
26
-165 vs prev Q
New positions
6
Closed positions
162
Increased
15
Reduced
7
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 414.0K +414.0K (+100.0%) | 5.18B +5.2B (+100.0%) | 0.29% +0.285 pp | 5.02% +5.016 pp | USD12.52 +0.0% | 1 qtrs NEW |
| 2 | NEA MANAGEMENT COMPANY, LLC | 13.22M +— (+0.0%) | 165.54M +44.6M (+36.8%) | 9.11% -1.031 pp | 8.44% +1.802 pp | USD3.18 +293.7% | 27 qtrs — |
| 3 | FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 10.26M +— (+0.0%) | 128.45M +34.6M (+36.8%) | 7.07% -0.800 pp | 3.45% +0.637 pp | USD2.53 +394.9% | 15 qtrs — |
| 4 | BLACKROCK, INC. | 10.13M +225.1K (+2.3%) | 126.78M +36.2M (+39.9%) | 6.98% -0.617 pp | 0.00% +0.001 pp | USD5.58 +124.4% | 6 qtrs — |
| 5 | FMR LLC | 6.50M +3.2M (+97.0%) | 81.38M +51.2M (+169.5%) | 4.48% +1.948 pp | 0.00% +0.003 pp | USD10.60 +18.1% | 11 qtrs — |
| 6 | VANGUARD GROUP INC | 6.43M +607.7K (+10.4%) | 80.56M +27.2M (+51.1%) | 4.43% -0.036 pp | 0.00% +0.000 pp | USD4.88 +156.6% | 27 qtrs — |
| 7 | VIVO CAPITAL, LLC | 5.09M +— (+0.0%) | 63.79M +17.2M (+36.8%) | 3.51% -0.397 pp | 4.12% +0.372 pp | USD4.74 +164.1% | 6 qtrs — |
| 8 | MARSHALL WACE, LLP | 4.58M -261.2K (-5.4%) | 57.35M +13.0M (+29.4%) | 3.16% -0.558 pp | 0.05% +0.007 pp | USD7.66 +63.4% | 6 qtrs — |
| 9 | RUBRIC CAPITAL MANAGEMENT LP | 3.77M -4.8M (-55.9%) | 47.16M -30.9M (-39.6%) | 2.60% -3.949 pp | 0.56% -0.317 pp | USD3.76 +233.0% | 15 qtrs — |
| 10 | WELLINGTON MANAGEMENT GROUP LLP | 3.40M +150.1K (+4.6%) | 42.62M +12.8M (+43.1%) | 2.35% -0.150 pp | 0.01% +0.002 pp | USD9.14 +37.0% | 4 qtrs — |
| 11 | BIOIMPACT CAPITAL LLC | 3.29M -119.9K (-3.5%) | 41.15M +10.0M (+32.0%) | 2.27% -0.348 pp | 4.71% -0.394 pp | USD3.97 +215.4% | 8 qtrs — |
| 12 | VIKING GLOBAL INVESTORS LP | 3.20M -1.9M (-37.6%) | 40.05M -6.9M (-14.7%) | 2.20% -1.730 pp | 0.11% -0.016 pp | USD6.86 +82.5% | 14 qtrs — |
| 13 | ORBIMED ADVISORS LLC | 3.19M -117.7K (-3.6%) | 39.95M +9.7M (+32.0%) | 2.20% -0.339 pp | 0.82% +0.105 pp | USD5.75 +117.7% | 4 qtrs — |
| 14 | ALLIANCEBERNSTEIN L.P. | 3.08M -1.2M (-28.2%) | 38.60M -676.9K (-1.7%) | 2.12% -1.168 pp | 0.01% 0.000 pp | USD5.47 +128.9% | 7 qtrs — |
| 15 | OCTAGON CAPITAL ADVISORS LP | 2.82M +— (+0.0%) | 35.24M +9.5M (+36.8%) | 1.94% -0.220 pp | 4.28% +0.375 pp | USD6.21 +101.6% | 4 qtrs — |
| 16 | EVENTIDE ASSET MANAGEMENT, LLC | 2.62M +1.2M (+89.8%) | 32.83M +20.2M (+159.8%) | 1.81% +0.748 pp | 0.51% +0.305 pp | USD8.81 +42.1% | 3 qtrs — |
| 17 | STATE STREET CORP | 2.44M +215.6K (+9.7%) | 30.49M +10.2M (+50.1%) | 1.68% -0.025 pp | 0.00% +0.000 pp | USD5.47 +128.9% | 16 qtrs — |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 2.41M +192.0K (+8.6%) | 30.21M +9.9M (+48.6%) | 1.66% -0.041 pp | 0.00% +0.001 pp | USD5.35 +134.0% | 27 qtrs — |
| 19 | SIREN, L.L.C. | 2.29M -250.0K (-9.9%) | 28.63M +5.4M (+23.3%) | 1.58% -0.370 pp | 0.85% -0.054 pp | USD4.49 +178.8% | 5 qtrs — |
| 20 | AFFINITY ASSET ADVISORS, LLC | 2.15M -649.8K (-23.2%) | 26.92M +1.3M (+5.1%) | 1.48% -0.666 pp | 1.53% -0.698 pp | USD6.19 +102.3% | 4 qtrs — |
| 21 | ACORN CAPITAL ADVISORS, LLC | 2.14M +— (+0.0%) | 26.85M +7.2M (+36.8%) | 1.48% -0.167 pp | 9.10% -0.864 pp | USD4.27 +193.2% | 5 qtrs — |
| 22 | ARTIA GLOBAL PARTNERS LP | 2.01M +13.9K (+0.7%) | 25.21M +6.9M (+37.8%) | 1.39% -0.146 pp | 4.02% +1.124 pp | USD6.78 +84.7% | 3 qtrs — |
| 23 | EMERALD ADVISERS, LLC | 1.89M +1.9M (+100.0%) | 23.69M +23.7M (+100.0%) | 1.30% +1.304 pp | 0.73% +0.730 pp | USD12.52 +0.0% | 1 qtrs NEW |
| 24 | RAYMOND JAMES FINANCIAL INC | 1.77M +355.9K (+25.2%) | 22.12M +9.2M (+71.3%) | 1.22% +0.135 pp | 0.01% +0.003 pp | USD7.81 +60.3% | 5 qtrs — |
| 25 | LOGOS GLOBAL MANAGEMENT LP | 1.55M -650.0K (-29.5%) | 19.41M -724.0K (-3.6%) | 1.07% -0.620 pp | 1.17% -0.632 pp | USD7.30 +71.5% | 8 qtrs — |
| 26 | PICTET ASSET MANAGEMENT HOLDING SA | 1.53M +1.5M (+13,507.0%) | 19.18M +19.1M (+18,518.5%) | 1.06% +1.047 pp | 0.02% +0.019 pp | USD12.50 +0.2% | 2 qtrs — |
| 27 | EMERALD MUTUAL FUND ADVISERS TRUST | 1.27M +1.3M (+100.0%) | 15.93M +15.9M (+100.0%) | 0.88% +0.877 pp | 0.78% +0.776 pp | USD12.52 +0.0% | 1 qtrs NEW |
| 28 | PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 1.26M +— (+0.0%) | 15.73M +4.2M (+36.8%) | 0.87% -0.098 pp | 6.08% -0.565 pp | USD5.79 +116.2% | 3 qtrs — |
| 29 | FRONTIER CAPITAL MANAGEMENT CO LLC | 1.11M +1.1M (+100.0%) | 13.88M +13.9M (+100.0%) | 0.76% +0.764 pp | 0.15% +0.147 pp | USD12.52 +0.0% | 1 qtrs NEW |
| 30 | BANK OF AMERICA CORP /DE/ | 1.09M -742.0K (-40.4%) | 13.71M -3.1M (-18.4%) | 0.75% -0.655 pp | 0.00% 0.000 pp | USD6.92 +80.9% | 13 qtrs — |
| 31 | GOLDMAN SACHS GROUP INC | 1.06M +269.4K (+34.2%) | 13.23M +6.0M (+83.6%) | 0.73% +0.124 pp | 0.00% +0.001 pp | USD8.56 +46.3% | 11 qtrs — |
| 32 | FLPUTNAM INVESTMENT MANAGEMENT CO | 1.05M +5.3K (+0.5%) | 13.19M +3.6M (+37.5%) | 0.73% -0.078 pp | 0.19% +0.048 pp | USD8.86 +41.3% | 3 qtrs — |
| 33 | MORGAN STANLEY | 1.05M -3.3M (-75.6%) | 13.15M -26.2M (-66.6%) | 0.72% -2.576 pp | 0.00% -0.002 pp | USD8.21 +52.5% | 16 qtrs — |
| 34 | WOODLINE PARTNERS LP | 1.00M +900.0K (+897.5%) | 12.52M +11.6M (+1,264.8%) | 0.69% +0.612 pp | 0.05% +0.044 pp | USD11.74 +6.6% | 6 qtrs — |
| 35 | POINT72 ASSET MANAGEMENT, L.P. | 1.00M +58.1K (+6.2%) | 12.52M +3.9M (+45.3%) | 0.69% -0.034 pp | 0.01% 0.000 pp | USD4.61 +171.6% | 5 qtrs — |
| 36 | NAN FUNG TRINITY (HK) LTD | 917.5K +827.9K (+924.2%) | 11.49M +10.7M (+1,301.5%) | 0.63% +0.564 pp | 0.91% +0.828 pp | USD12.19 +2.7% | 2 qtrs — |
| 37 | SOLEUS CAPITAL MANAGEMENT, L.P. | 900.0K +875.0K (+3,500.0%) | 11.27M +11.0M (+4,825.9%) | 0.62% +0.601 pp | 0.42% +0.404 pp | USD12.32 +1.6% | 3 qtrs — |
| 38 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 836.8K +30.5K (+3.8%) | 10.48M +3.1M (+42.0%) | 0.58% -0.042 pp | 0.00% +0.001 pp | USD7.75 +61.5% | 15 qtrs — |
| 39 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 825.5K -775.2K (-48.4%) | 10.34M -4.3M (-29.4%) | 0.57% -0.659 pp | 0.00% -0.001 pp | USD8.89 +40.8% | 6 qtrs — |
| 40 | NORTHERN TRUST CORP | 762.0K +25.0K (+3.4%) | 9.54M +2.8M (+41.5%) | 0.53% -0.040 pp | 0.00% +0.000 pp | USD4.94 +153.4% | 27 qtrs — |
| 41 | PANAGORA ASSET MANAGEMENT INC | 693.0K +122.5K (+21.5%) | 8.68M +3.5M (+66.2%) | 0.48% +0.040 pp | 0.03% +0.010 pp | USD6.72 +86.3% | 6 qtrs — |
| 42 | SPHERA FUNDS MANAGEMENT LTD. | 598.5K -45.4K (-7.1%) | 7.49M +1.6M (+27.2%) | 0.41% -0.082 pp | 1.45% +0.206 pp | USD5.47 +128.9% | 3 qtrs — |
| 43 | BARCLAYS PLC | 582.7K +487.4K (+511.8%) | 7.29M +7.0M (+2,193.4%) | 0.40% +0.329 pp | 0.00% +0.002 pp | USD11.27 +11.1% | 11 qtrs — |
| 44 | MILLENNIUM MANAGEMENT LLC | 570.2K -157.4K (-21.6%) | 7.14M +481.7K (+7.2%) | 0.39% -0.165 pp | 0.00% +0.000 pp | USD8.42 +48.7% | 6 qtrs — |
| 45 | PRUDENTIAL FINANCIAL INC | 549.2K -53.4K (-8.9%) | 6.88M +1.4M (+24.7%) | 0.38% -0.084 pp | 0.01% +0.002 pp | USD7.77 +61.1% | 3 qtrs — |
| 46 | EAM INVESTORS, LLC | 541.2K -8.2K (-1.5%) | 6.78M +1.8M (+36.5%) | 0.37% -0.049 pp | 0.75% +0.186 pp | USD6.62 +89.1% | 4 qtrs — |
| 47 | SILVERARC CAPITAL MANAGEMENT, LLC | 541.2K -47.5K (-8.1%) | 6.78M +1.4M (+25.8%) | 0.37% -0.079 pp | 0.94% +0.215 pp | USD3.08 +306.5% | 14 qtrs — |
| 48 | BURKEHILL GLOBAL MANAGEMENT, LP | 525.0K +— (+0.0%) | 6.57M +1.8M (+36.8%) | 0.36% -0.041 pp | 0.43% +0.160 pp | USD5.47 +128.9% | 3 qtrs — |
| 49 | PEREGRINE CAPITAL MANAGEMENT LLC | 507.7K -112.8K (-18.2%) | 6.36M +679.0K (+12.0%) | 0.35% -0.126 pp | 0.19% +0.024 pp | USD9.15 +36.8% | 2 qtrs — |
| 50 | INVESCO LTD. | 498.9K +15.9K (+3.3%) | 6.25M +1.8M (+41.3%) | 0.34% -0.027 pp | 0.00% +0.000 pp | USD7.34 +70.6% | 11 qtrs — |
| 51 | J. GOLDMAN & CO LP | 444.4K -348.4K (-44.0%) | 5.56M -1.7M (-23.3%) | 0.31% -0.302 pp | 0.15% -0.036 pp | USD5.11 +145.0% | 15 qtrs — |
| 52 | STEMPOINT CAPITAL LP | 399.6K +48.8K (+13.9%) | 5.00M +1.8M (+55.9%) | 0.28% +0.006 pp | 0.86% +0.215 pp | USD9.56 +31.0% | 2 qtrs — |
| 53 | OPALEYE MANAGEMENT INC. | 345.1K -44.9K (-11.5%) | 4.32M +752.2K (+21.1%) | 0.24% -0.061 pp | 0.57% +0.066 pp | USD1.94 +545.4% | 13 qtrs — |
| 54 | AMERIPRISE FINANCIAL INC | 324.2K +324.2K (+100.0%) | 4.06M +4.1M (+100.0%) | 0.22% +0.223 pp | 0.00% +0.001 pp | USD12.52 +0.0% | 8 qtrs — |
| 55 | UBS GROUP AG | 274.6K -24.0K (-8.0%) | 3.44M +706.0K (+25.8%) | 0.19% -0.040 pp | 0.00% +0.000 pp | USD5.30 +136.2% | 20 qtrs — |
| 56 | BANK OF NEW YORK MELLON CORP | 260.6K +34.2K (+15.1%) | 3.26M +1.2M (+57.5%) | 0.18% +0.006 pp | 0.00% +0.000 pp | USD5.73 +118.5% | 14 qtrs — |
| 57 | F/M INVESTMENTS LLC | 241.5K +241.5K (+100.0%) | 3.02M +3.0M (+100.0%) | 0.17% +0.166 pp | 0.11% +0.115 pp | USD12.52 +0.0% | 1 qtrs NEW |
| 58 | VOYA INVESTMENT MANAGEMENT LLC | 226.2K +211.0K (+1,390.2%) | 2.83M +2.7M (+1,939.1%) | 0.16% +0.144 pp | 0.00% +0.003 pp | USD11.90 +5.2% | 11 qtrs — |
| 59 | VELAN CAPITAL INVESTMENT MANAGEMENT LP | 205.0K +— (+0.0%) | 2.57M +690.9K (+36.8%) | 0.14% -0.016 pp | 1.49% -0.273 pp | USD9.15 +36.8% | 2 qtrs — |
| 60 | NUVEEN, LLC | 183.3K +— (+0.0%) | 2.30M +617.8K (+36.8%) | 0.13% -0.014 pp | 0.00% +0.000 pp | USD6.51 +92.3% | 4 qtrs — |
| 61 | BALYASNY ASSET MANAGEMENT L.P. | 174.6K -451.8K (-72.1%) | 2.19M -3.5M (-61.9%) | 0.12% -0.360 pp | 0.00% -0.005 pp | USD6.08 +105.9% | 4 qtrs — |
| 62 | SWISS NATIONAL BANK | 168.2K +6.5K (+4.0%) | 2.11M +626.3K (+42.3%) | 0.12% -0.008 pp | 0.00% +0.000 pp | USD9.28 +34.9% | 2 qtrs — |
| 63 | FRED ALGER MANAGEMENT, LLC | 158.0K -33.1K (-17.3%) | 1.98M +229.8K (+13.1%) | 0.11% -0.038 pp | 0.01% +0.001 pp | USD8.26 +51.6% | 6 qtrs — |
| 64 | SUPERSTRING CAPITAL MANAGEMENT LP | 148.3K +148.3K (+100.0%) | 1.86M +1.9M (+100.0%) | 0.10% +0.102 pp | 0.99% +0.994 pp | USD12.52 +0.0% | 1 qtrs NEW |
| 65 | SEI INVESTMENTS CO | 147.9K +62.1K (+72.4%) | 1.85M +1.1M (+135.9%) | 0.10% +0.036 pp | 0.00% +0.001 pp | USD10.57 +18.4% | 2 qtrs — |
| 66 | D. E. SHAW & CO., INC. | 141.3K +141.3K (+100.0%) | 1.77M +1.8M (+100.0%) | 0.10% +0.097 pp | 0.00% +0.001 pp | USD12.52 +0.0% | 1 qtrs NEW |
| 67 | UBS ASSET MANAGEMENT AMERICAS INC | 140.7K +24.3K (+20.8%) | 1.76M +696.2K (+65.3%) | 0.10% +0.008 pp | 0.00% +0.000 pp | USD9.73 +28.7% | 2 qtrs — |
| 68 | BIT CAPITAL GMBH | 130.0K +123.3K (+1,829.1%) | 1.63M +1.6M (+2,539.6%) | 0.09% +0.084 pp | 0.06% +0.058 pp | USD12.23 +2.4% | 4 qtrs — |
| 69 | HRT FINANCIAL LP | 125.1K +125.1K (+100.0%) | 1.57M +1.6M (+100.0%) | 0.09% +0.086 pp | 0.00% +0.005 pp | USD12.52 +0.0% | 1 qtrs NEW |
| 70 | SG AMERICAS SECURITIES, LLC | 124.6K +60.0K (+93.0%) | 1.56M +969.0K (+164.0%) | 0.09% +0.036 pp | 0.00% +0.000 pp | USD10.77 +16.2% | 10 qtrs — |
| 71 | CITIGROUP INC | 123.5K +96.6K (+358.9%) | 1.55M +1.3M (+527.9%) | 0.09% +0.065 pp | 0.00% +0.001 pp | USD10.61 +18.0% | 11 qtrs — |
| 72 | STATE OF WISCONSIN INVESTMENT BOARD | 120.6K -2.7K (-2.2%) | 1.51M +381.5K (+33.8%) | 0.08% -0.012 pp | 0.00% +0.001 pp | USD5.67 +120.8% | 5 qtrs — |
| 73 | HIGHVISTA STRATEGIES LLC | 106.2K +106.2K (+100.0%) | 1.33M +1.3M (+100.0%) | 0.07% +0.073 pp | 0.34% +0.342 pp | USD12.52 +0.0% | 1 qtrs NEW |
| 74 | RHUMBLINE ADVISERS | 105.9K -9.1K (-7.9%) | 1.33M +273.7K (+26.0%) | 0.07% -0.015 pp | 0.00% +0.000 pp | USD3.83 +226.9% | 11 qtrs — |
| 75 | WELLS FARGO & COMPANY/MN | 101.3K +45.6K (+81.9%) | 1.27M +758.5K (+148.9%) | 0.07% +0.027 pp | 0.00% +0.000 pp | USD8.44 +48.3% | 13 qtrs — |
| 76 | OPPENHEIMER & CO INC | 100.7K +2.0K (+2.1%) | 1.26M +357.9K (+39.6%) | 0.07% -0.006 pp | 0.02% +0.007 pp | USD4.08 +206.9% | 8 qtrs — |
| 77 | LMR PARTNERS LLP | 100.0K +— (+0.0%) | 1.25M +337.0K (+36.8%) | 0.07% -0.008 pp | 0.00% -0.002 pp | USD6.29 +99.0% | 4 qtrs — |
| 78 | ROSALIND ADVISORS, INC. | 100.0K +— (+0.0%) | 1.25M +337.0K (+36.8%) | 0.07% -0.008 pp | 0.44% +0.127 pp | USD2.52 +396.8% | 9 qtrs — |
| 79 | DIADEMA PARTNERS LP | 97.2K +11.4K (+13.2%) | 1.22M +431.4K (+54.9%) | 0.07% +0.001 pp | 0.21% +0.009 pp | USD7.00 +78.9% | 4 qtrs — |
| 80 | ERSTE ASSET MANAGEMENT GMBH | 90.0K +90.0K (+100.0%) | 1.15M +1.2M (+100.0%) | 0.06% +0.062 pp | 0.01% +0.010 pp | USD12.52 +0.0% | 1 qtrs NEW |
| 81 | CITADEL ADVISORS LLC | 90.0K -142.0K (-61.2%) | 1.13M -996.0K (-46.9%) | 0.06% -0.116 pp | 0.00% 0.000 pp | USD7.62 +64.3% | 9 qtrs — |
| 82 | SECTORAL ASSET MANAGEMENT INC | 84.3K -21.7K (-20.5%) | 1.05M +85.4K (+8.8%) | 0.06% -0.023 pp | 0.85% +0.247 pp | USD5.97 +109.7% | 4 qtrs — |
| 83 | XTX TOPCO LTD | 83.8K +83.8K (+100.0%) | 1.05M +1.0M (+100.0%) | 0.06% +0.058 pp | 0.03% +0.028 pp | USD12.52 +0.0% | 5 qtrs — |
| 84 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 83.8K +2.1K (+2.6%) | 1.05M +301.5K (+40.3%) | 0.06% -0.005 pp | 0.00% +0.000 pp | USD8.88 +41.0% | 11 qtrs — |
| 85 | TWO SIGMA INVESTMENTS, LP | 83.8K -36.2K (-30.2%) | 1.05M -48.7K (-4.4%) | 0.06% -0.034 pp | 0.00% 0.000 pp | USD4.15 +201.7% | 5 qtrs — |
| 86 | COMERICA BANK | 83.0K +82.6K (+19,481.8%) | 1.04M +1.0M (+26,691.2%) | 0.06% +0.057 pp | 0.00% +0.004 pp | USD12.48 +0.3% | 3 qtrs — |
| 87 | WEXFORD CAPITAL LP | 82.0K +82.0K (+100.0%) | 1.03M +1.0M (+100.0%) | 0.06% +0.057 pp | 0.20% +0.198 pp | USD12.52 +0.0% | 1 qtrs NEW |
| 88 | LEGAL & GENERAL GROUP PLC | 81.7K -299.0 (-0.4%) | 1.02M +272.5K (+36.3%) | 0.06% -0.007 pp | 0.00% +0.000 pp | USD8.55 +46.4% | 11 qtrs — |
| 89 | PFS PARTNERS, LLC | 79.0K +— (+0.0%) | 989.1K +266.2K (+36.8%) | 0.05% -0.006 pp | 0.45% +0.109 pp | USD2.39 +423.8% | 11 qtrs — |
| 90 | MAI CAPITAL MANAGEMENT | 77.8K -20.7K (-21.0%) | 973.7K +72.5K (+8.0%) | 0.05% -0.022 pp | 0.01% +0.000 pp | USD2.55 +391.0% | 16 qtrs — |
| 91 | HUDSON BAY CAPITAL MANAGEMENT LP | 75.0K +75.0K (+100.0%) | 939.0K +939.0K (+100.0%) | 0.05% +0.052 pp | 0.00% +0.003 pp | USD12.52 +0.0% | 1 qtrs NEW |
| 92 | CAMPBELL & CO INVESTMENT ADVISER LLC | 71.1K +46.2K (+185.7%) | 890.1K +662.4K (+290.9%) | 0.05% +0.030 pp | 0.04% +0.026 pp | USD10.63 +17.8% | 3 qtrs — |
| 93 | DEUTSCHE BANK AG\ | 70.8K +19.2K (+37.2%) | 886.8K +414.3K (+87.7%) | 0.05% +0.009 pp | 0.00% +0.000 pp | USD7.04 +77.8% | 10 qtrs — |
| 94 | JANE STREET GROUP, LLC | 69.1K -133.5K (-65.9%) | 865.1K -988.7K (-53.3%) | 0.05% -0.108 pp | 0.00% 0.000 pp | USD7.52 +66.5% | 3 qtrs — |
| 95 | TUDOR INVESTMENT CORP ET AL | 68.5K +68.5K (+100.0%) | 857.4K +857.4K (+100.0%) | 0.05% +0.047 pp | 0.00% +0.002 pp | USD12.52 +0.0% | 1 qtrs NEW |
| 96 | WEALTHTRUST AXIOM LLC | 61.5K +— (+0.0%) | 770.0K +207.3K (+36.8%) | 0.04% -0.005 pp | 0.20% +0.047 pp | USD2.37 +428.3% | 21 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
6
Sells
0
Shares acquired
1.55M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+1,545,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | Simon Farrell | Officer | A-Award | A | Stock Option (right to buy) | 160,000 | 10.56 | 1.69M | 160,000 | D | ↗ |
| 2026-02-19 | SCIASCIA THOMAS | Officer | A-Award | A | Stock Option (right to buy) | 85,000 | 10.56 | 897.6K | 85,000 | D | ↗ |
| 2026-02-19 | Galletta Christopher | Officer | A-Award | A | Stock Option (right to buy) | 35,000 | 10.56 | 369.6K | 35,000 | D | ↗ |
| 2026-02-19 | GOOD JENNIFER L | Director / Officer | A-Award | A | Stock Option (right to buy) | 675,000 | 10.56 | 7.13M | 675,000 | D | ↗ |
| 2026-02-19 | Cassella James V | Officer | A-Award | A | Stock Option (right to buy) | 215,000 | 10.56 | 2.27M | 215,000 | D | ↗ |
| 2026-01-08 | HASTINGS DAVID C | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-31 | Walker Paul Edward | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 948,948 | I | ↗ |
| 2025-12-31 | SANDELL SCOTT D | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 948,948 | I | ↗ |
| 2025-12-31 | Makhzoumi Mohamad | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 948,948 | I | ↗ |
| 2025-12-31 | Florence Anthony A. Jr. | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 948,948 | I | ↗ |
| 2025-12-31 | Chang Carmen | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 948,948 | I | ↗ |
| 2025-12-31 | Behbahani Ali | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 948,948 | I | ↗ |
| 2025-12-02 | Galletta Christopher | Officer | M-Exempt | A | Common Stock | 4,225 | 0.51 | 2.2K | 26,095 | D | ↗ |
| 2025-06-11 | VANLENT ANNE | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 45,000 | 6.25 | 281.3K | 45,000 | D | ↗ |
| 2025-06-11 | Meeker David P | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 45,000 | 6.25 | 281.3K | 45,000 | D | ↗ |
| 2025-06-11 | Mathers Edward T | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 45,000 | 6.25 | 281.3K | 45,000 | D | ↗ |
| 2025-06-11 | Heffernan Michael Thomas | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 45,000 | 6.25 | 281.3K | 45,000 | D | ↗ |
| 2025-06-11 | Colangelo Dominick | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 45,000 | 6.25 | 281.3K | 45,000 | D | ↗ |
| 2025-05-31 | Simon Farrell | Officer | A-Award | A | Performance Stock Option (right to buy) | 72,000 | 2.38 | 171.4K | 110,400 | D | ↗ |
| 2025-05-31 | SCIASCIA THOMAS | Officer | A-Award | A | Performance Stock Option (right to buy) | 60,000 | 2.38 | 142.8K | 92,000 | D | ↗ |
| 2025-05-31 | Galletta Christopher | Officer | A-Award | A | Performance Stock Option (right to buy) | 8,550 | 2.38 | 20.3K | 13,110 | D | ↗ |
| 2025-05-31 | GOOD JENNIFER L | Director / Officer | A-Award | A | Performance Stock Option (right to buy) | 102,000 | 2.38 | 242.8K | 156,400 | D | ↗ |
| 2025-05-31 | Delfini Lisa | Officer | A-Award | A | Performance Stock Option (right to buy) | 72,000 | 2.38 | 171.4K | 110,400 | D | ↗ |
| 2025-04-17 | Walker Paul Edward | 10% Owner | X-InTheMoney | D | 3.5-Year Common Stock Warrant | 1,851,852 | 1.37 | 2.54M | 0 | I | ↗ |
| 2025-04-17 | SANDELL SCOTT D | 10% Owner | X-InTheMoney | D | 3.5-Year Common Stock Warrant | 1,851,852 | 1.37 | 2.54M | 0 | I | ↗ |
| 2025-04-17 | New Enterprise Associates 16, L.P. | 10% Owner | X-InTheMoney | D | 3.5-Year Common Stock Warrant | 1,851,852 | 1.37 | 2.54M | 0 | D | ↗ |
| 2025-04-17 | Makhzoumi Mohamad | 10% Owner | X-InTheMoney | D | 3.5-Year Common Stock Warrant | 1,851,852 | 1.37 | 2.54M | 0 | I | ↗ |
| 2025-04-17 | Florence Anthony A. Jr. | 10% Owner | X-InTheMoney | D | 3.5-Year Common Stock Warrant | 1,851,852 | 1.37 | 2.54M | 0 | I | ↗ |
| 2025-04-17 | Chang Carmen | 10% Owner | X-InTheMoney | D | 3.5-Year Common Stock Warrant | 1,851,852 | 1.37 | 2.54M | 0 | I | ↗ |
| 2025-04-17 | Behbahani Ali | 10% Owner | X-InTheMoney | D | 3.5-Year Common Stock Warrant | 1,851,852 | 1.37 | 2.54M | 0 | I | ↗ |
| 2025-04-17 | BASKETT FOREST | 10% Owner | X-InTheMoney | D | 3.5-Year Common Stock Warrant | 1,851,852 | 1.37 | 2.54M | 0 | I | ↗ |
| 2025-03-25 | SCIASCIA THOMAS | Officer | M-Exempt | D | Stock Option (right to buy) | 2,631 | 1.43 | 3.8K | 0 | D | ↗ |
| 2025-03-21 | GOOD JENNIFER L | Director / Officer | M-Exempt | A | Common Stock | 5,263 | 1.43 | 7.5K | 218,576 | D | ↗ |
| 2025-03-10 | Simon Farrell | Officer | S-Sale | D | Common Stock | 76,963 | 6.73 | 517.8K | 81,250 | D | ↗ |
| 2025-03-10 | SCIASCIA THOMAS | Officer | A-Award | A | Performance Stock Option (right to buy) | 32,000 | 2.38 | 76.2K | 32,000 | D | ↗ |
| 2025-03-10 | Galletta Christopher | Officer | A-Award | A | Performance Stock Option (right to buy) | 4,560 | 2.38 | 10.9K | 4,560 | D | ↗ |
| 2025-03-10 | GOOD JENNIFER L | Director / Officer | A-Award | A | Performance Stock Option (right to buy) | 54,400 | 2.38 | 129.5K | 54,400 | D | ↗ |
| 2025-03-10 | Delfini Lisa | Officer | A-Award | A | Performance Stock Option (right to buy) | 38,400 | 2.38 | 91.4K | 38,400 | D | ↗ |
| 2025-02-18 | Simon Farrell | Officer | A-Award | A | Stock Option (right to buy) | 225,500 | 4.22 | 951.6K | 225,500 | D | ↗ |
| 2025-02-18 | SCIASCIA THOMAS | Officer | A-Award | A | Stock Option (right to buy) | 116,000 | 4.22 | 489.5K | 116,000 | D | ↗ |
| 2025-02-18 | Galletta Christopher | Officer | A-Award | A | Stock Option (right to buy) | 41,000 | 4.22 | 173.0K | 41,000 | D | ↗ |
| 2025-02-18 | GOOD JENNIFER L | Director / Officer | A-Award | A | Stock Option (right to buy) | 811,000 | 4.22 | 3.42M | 811,000 | D | ↗ |
| 2025-02-18 | Delfini Lisa | Officer | A-Award | A | Stock Option (right to buy) | 225,500 | 4.22 | 951.6K | 225,500 | D | ↗ |
| 2025-02-18 | Cassella James V | Officer | A-Award | A | Stock Option (right to buy) | 257,500 | 4.22 | 1.09M | 257,500 | D | ↗ |
| 2025-01-08 | Delfini Lisa | Officer | M-Exempt | A | Common Stock | 5,000 | 0.51 | 2.6K | 64,660 | D | ↗ |
| 2025-01-07 | Delfini Lisa | Officer | M-Exempt | A | Common Stock | 1,000 | 0.51 | 511.00 | 59,660 | D | ↗ |
| 2024-12-13 | Galletta Christopher | Officer | M-Exempt | D | Stock Option (right to buy) | 15,000 | 0.51 | 7.7K | 20,000 | D | ↗ |
| 2024-09-30 | Cassella James V | Officer | A-Award | A | Stock Option (right to buy) | 400,000 | 3.34 | 1.34M | 400,000 | D | ↗ |
| 2024-09-09 | GOOD JENNIFER L | Director / Officer | M-Exempt | A | Common Stock | 1,840 | 1.43 | 2.6K | 215,153 | — | ↗ |
| 2024-09-06 | GOOD JENNIFER L | Director / Officer | M-Exempt | A | Common Stock | 4,219 | 1.43 | 6.0K | 217,532 | — | ↗ |
| 2024-09-05 | GOOD JENNIFER L | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 40,277 | 1.43 | 57.6K | 6,059 | — | ↗ |
| 2024-09-04 | GOOD JENNIFER L | Director / Officer | S-Sale | D | Common Stock | 10,981 | 3.02 | 33.2K | 213,313 | — | ↗ |
| 2024-09-03 | GOOD JENNIFER L | Director / Officer | M-Exempt | A | Common Stock | 3,863 | 1.43 | 5.5K | 217,176 | — | ↗ |
| 2024-08-27 | Meeker David P | Director | S-Sale | D | Common Stock | 4,555 | 2.93 | 13.4K | 352,489 | — | ↗ |
| 2024-08-19 | SCIASCIA THOMAS | Officer | M-Exempt | A | Common Stock | 16,496 | 1.43 | 23.6K | 236,811 | — | ↗ |
| 2024-08-16 | SCIASCIA THOMAS | Officer | S-Sale | D | Common Stock | 18,660 | 2.76 | 51.4K | 220,315 | — | ↗ |
| 2024-08-15 | SCIASCIA THOMAS | Officer | M-Exempt | A | Common Stock | 12,745 | 1.43 | 18.2K | 233,060 | — | ↗ |
| 2024-08-14 | SCIASCIA THOMAS | Officer | M-Exempt | A | Common Stock | 100 | 1.43 | 143.00 | 220,415 | — | ↗ |
| 2024-06-13 | Meeker David P | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 30,000 | 2.77 | 83.1K | 30,000 | — | ↗ |
| 2024-06-13 | Mathers Edward T | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 30,000 | 2.77 | 83.1K | 30,000 | — | ↗ |
| 2024-06-13 | Heffernan Michael Thomas | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 30,000 | 2.77 | 83.1K | 30,000 | — | ↗ |
| 2024-06-13 | Colangelo Dominick | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 30,000 | 2.77 | 83.1K | 30,000 | — | ↗ |
| 2024-06-13 | Cassella James V | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 30,000 | 2.77 | 83.1K | 30,000 | — | ↗ |
| 2024-05-29 | SCIASCIA THOMAS | Officer | M-Exempt | A | Common Stock | 59,354 | 2.19 | 130.0K | 267,801 | — | ↗ |
| 2024-05-22 | Delfini Lisa | Officer | M-Exempt | A | Common Stock | 16,043 | 0.51 | 8.2K | 57,629 | — | ↗ |
| 2024-05-20 | GOOD JENNIFER L | Director / Officer | M-Exempt | A | Common Stock | 25,037 | 2.19 | 54.8K | 238,350 | — | ↗ |
| 2024-05-10 | GOOD JENNIFER L | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 4,578 | 2.19 | 10.0K | 58,226 | — | ↗ |
| 2024-02-15 | Simon Farrell | Officer | A-Award | A | Stock Option (right to buy) | 175,000 | 2.38 | 416.5K | 175,000 | — | ↗ |
| 2024-02-15 | SCIASCIA THOMAS | Officer | A-Award | A | Stock Option (right to buy) | 150,000 | 2.38 | 357.0K | 150,000 | — | ↗ |
| 2024-02-15 | Galletta Christopher | Officer | A-Award | A | Stock Option (right to buy) | 28,500 | 2.38 | 67.8K | 28,500 | — | ↗ |
| 2024-02-15 | GOOD JENNIFER L | Director / Officer | A-Award | A | Stock Option (right to buy) | 630,000 | 2.38 | 1.50M | 630,000 | — | ↗ |
| 2024-02-15 | Delfini Lisa | Officer | A-Award | A | Stock Option (right to buy) | 175,000 | 2.38 | 416.5K | 175,000 | — | ↗ |
| 2024-02-15 | Clark David J | Officer | A-Award | A | Stock Option (right to buy) | 175,000 | 2.38 | 416.5K | 175,000 | — | ↗ |
| 2023-10-11 | Delfini Lisa | Officer | M-Exempt | D | Stock Option (right to buy) | 2,292 | 0.51 | 1.2K | 64,168 | — | ↗ |
| 2023-09-11 | Delfini Lisa | Officer | M-Exempt | D | Stock Option (right to buy) | 2,291 | 0.51 | 1.2K | 66,460 | — | ↗ |
| 2023-08-11 | Delfini Lisa | Officer | M-Exempt | A | Common Stock | 2,292 | 0.51 | 1.2K | 33,496 | — | ↗ |
| 2023-07-11 | Delfini Lisa | Officer | M-Exempt | A | Common Stock | 2,292 | 0.51 | 1.2K | 31,891 | — | ↗ |
| 2023-06-28 | VANLENT ANNE | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 30,000 | 2.27 | 68.1K | 30,000 | — | ↗ |
| 2023-06-28 | Meeker David P | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 30,000 | 2.27 | 68.1K | 30,000 | — | ↗ |
| 2023-06-28 | Mathers Edward T | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 30,000 | 2.27 | 68.1K | 30,000 | — | ↗ |
| 2023-06-28 | Heffernan Michael Thomas | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 30,000 | 2.27 | 68.1K | 30,000 | — | ↗ |
| 2023-06-28 | Colangelo Dominick | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 30,000 | 2.27 | 68.1K | 30,000 | — | ↗ |
| 2023-06-28 | Cassella James V | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 30,000 | 2.27 | 68.1K | 30,000 | — | ↗ |
| 2023-06-20 | Simon Farrell | Officer | M-Exempt | D | Stock Option (right to buy) | 6,250 | 0.51 | 3.2K | 50,000 | — | ↗ |
| 2023-06-12 | Delfini Lisa | Officer | M-Exempt | D | Stock Option (right to buy) | 2,291 | 0.51 | 1.2K | 73,335 | — | ↗ |
| 2023-05-11 | Delfini Lisa | Officer | M-Exempt | A | Common Stock | 2,291 | 0.51 | 1.2K | 28,480 | — | ↗ |
| 2023-04-11 | Delfini Lisa | Officer | M-Exempt | D | Stock Option (right to buy) | 2,292 | 0.51 | 1.2K | 77,917 | — | ↗ |
| 2023-03-13 | Delfini Lisa | Officer | M-Exempt | D | Stock Option (right to buy) | 2,291 | 0.51 | 1.2K | 80,209 | — | ↗ |
| 2023-03-07 | Simon Farrell | Officer | M-Exempt | D | Stock Option (right to buy) | 18,750 | 0.51 | 9.6K | 56,250 | — | ↗ |
| 2023-02-16 | Simon Farrell | Officer | — | D | Stock Option (right to buy) | 75,000 | 3.91 | 293.3K | 0 | — | ↗ |
| 2023-02-16 | SCIASCIA THOMAS | Officer | A-Award | A | Stock Option (right to buy) | 187,500 | 2.67 | 500.6K | 187,500 | — | ↗ |
| 2023-02-16 | Galletta Christopher | Officer | A-Award | A | Stock Option (right to buy) | 40,000 | 2.67 | 106.8K | 40,000 | — | ↗ |
| 2023-02-16 | GOOD JENNIFER L | Director / Officer | A-Award | A | Stock Option (right to buy) | 375,000 | 2.67 | 1.00M | 375,000 | — | ↗ |
| 2023-02-16 | Delfini Lisa | Officer | A-Award | A | Stock Option (right to buy) | 187,500 | 2.67 | 500.6K | 187,500 | — | ↗ |
| 2023-02-13 | Delfini Lisa | Officer | M-Exempt | D | Stock Option (right to buy) | 27,500 | 0.51 | 14.1K | 82,500 | — | ↗ |
| 2022-11-14 | Clark David J | Officer | A-Award | A | Stock Option (right to buy) | 300,000 | 0.00 | — | 300,000 | — | ↗ |
| 2022-09-19 | SCIASCIA THOMAS | Officer | A-Award | A | Performance Stock Options (right to buy) | 7,500 | 3.21 | 24.1K | 37,500 | — | ↗ |
| 2022-09-19 | GOOD JENNIFER L | Director / Officer | A-Award | A | Performance Stock Options (right to buy) | 32,000 | 3.21 | 102.7K | 160,000 | — | ↗ |
| 2022-07-05 | TPG GP A, LLC | 10% Owner | S-Sale | D | Common Stock | 63,569 | 3.11 | 197.8K | 3,824,883 | — | ↗ |
| 2022-07-01 | WINKELRIED JON | Director | S-Sale | D | Common Stock | 63,569 | 3.11 | 197.8K | 3,824,883 | — | ↗ |
| 2022-07-01 | TPG GP A, LLC | 10% Owner | S-Sale | D | Common Stock | 436,431 | 2.86 | 1.25M | 3,888,452 | — | ↗ |
| 2022-06-30 | TPG GP A, LLC | 10% Owner | S-Sale | D | Common Stock | 429,838 | 2.77 | 1.19M | 4,324,883 | — | ↗ |
| 2022-06-29 | WINKELRIED JON | Director | S-Sale | D | Common Stock | 46,128 | 2.74 | 126.3K | 4,754,721 | — | ↗ |
| 2022-06-29 | TPG GP A, LLC | 10% Owner | S-Sale | D | Common Stock | 46,128 | 2.74 | 126.3K | 4,754,721 | — | ↗ |
| 2022-06-29 | SCIASCIA THOMAS | Officer | A-Award | A | Performance Stock Options (right to buy) | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2022-06-29 | GOOD JENNIFER L | Director / Officer | A-Award | A | Performance Stock Options (right to buy) | 128,000 | 3.21 | 410.9K | 128,000 | — | ↗ |
| 2022-06-29 | Forbes William P | Officer | A-Award | A | Performance Stock Options (right to buy) | 48,000 | 3.21 | 154.1K | 48,000 | — | ↗ |
| 2022-06-23 | VANLENT ANNE | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-06-23 | Meeker David P | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-06-23 | Mathers Edward T | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-06-23 | Heffernan Michael Thomas | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 2.27 | 45.4K | 20,000 | — | ↗ |
| 2022-06-23 | Colangelo Dominick | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 2.27 | 45.4K | 20,000 | — | ↗ |
| 2022-06-23 | Cassella James V | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-05-02 | WINKELRIED JON | Director | S-Sale | D | Common Stock | 600 | 2.70 | 1.6K | 4,800,849 | — | ↗ |
| 2022-05-02 | TPG GP A, LLC | 10% Owner | S-Sale | D | Common Stock | 600 | 2.70 | 1.6K | 4,800,849 | — | ↗ |
| 2022-04-29 | TPG GP A, LLC | 10% Owner | S-Sale | D | Common Stock | 16,163 | 2.75 | 44.4K | 4,801,449 | — | ↗ |
| 2022-04-28 | WINKELRIED JON | Director | S-Sale | D | Common Stock | 16,163 | 2.75 | 44.4K | 4,801,449 | — | ↗ |
| 2022-04-28 | TPG GP A, LLC | 10% Owner | S-Sale | D | Common Stock | 7,271 | 2.77 | 20.1K | 4,817,612 | — | ↗ |
| 2022-04-11 | Walker Paul Edward | Director | P-Purchase | A | Pre-Funded Warrants | 3,000,000 | 1.90 | 5.70M | 3,000,000 | — | ↗ |
| 2022-04-11 | Sonsini Peter W. | Director | P-Purchase | A | Common Stock | 948,948 | 1.90 | 1.80M | 948,948 | — | ↗ |
| 2022-04-11 | SANDELL SCOTT D | 10% Owner | P-Purchase | A | Common Stock | 948,948 | 1.90 | 1.80M | 948,948 | — | ↗ |
| 2022-04-11 | New Enterprise Associates 16, L.P. | 10% Owner | P-Purchase | A | Common Stock | 2,631,578 | 1.90 | 5.00M | 10,421,428 | — | ↗ |
| 2022-04-11 | NEA 16 GP, LLC | Director | P-Purchase | A | Common Stock | 2,631,578 | 1.90 | 5.00M | 10,421,428 | — | ↗ |
| 2022-04-11 | Mathers Edward T | Director | A-Award | A | Common Stock | 948,948 | 1.90 | 1.80M | 948,948 | — | ↗ |
| 2022-04-11 | Makhzoumi Mohamad | 10% Owner | P-Purchase | A | Pre-Funded Warrants | 3,000,000 | 0.00 | 3.0K | 3,000,000 | — | ↗ |
| 2022-04-11 | Florence Anthony A. Jr. | Director | P-Purchase | A | Common Stock | 948,948 | 1.90 | 1.80M | 948,948 | — | ↗ |
| 2022-04-11 | Chang Carmen | 10% Owner | P-Purchase | A | Common Stock | 2,631,578 | 1.90 | 5.00M | 10,421,428 | — | ↗ |
| 2022-04-11 | Behbahani Ali | 10% Owner | P-Purchase | A | Common Stock | 2,631,578 | 1.90 | 5.00M | 10,421,428 | — | ↗ |
| 2022-04-11 | BASKETT FOREST | Director | P-Purchase | A | Common Stock | 2,631,578 | 1.90 | 5.00M | 10,421,428 | — | ↗ |
| 2022-02-14 | GOOD JENNIFER L | Director / Officer | A-Award | A | Stock Option (right to buy) | 275,000 | 0.51 | 139.5K | 275,000 | — | ↗ |
| 2022-02-11 | SCIASCIA THOMAS | Officer | A-Award | A | Stock Option (right to buy) | 110,000 | 0.51 | 56.2K | 110,000 | — | ↗ |
| 2022-02-11 | Galletta Christopher | Officer | A-Award | A | Stock Option (right to buy) | 35,000 | 0.51 | 17.9K | 35,000 | — | ↗ |
| 2022-02-11 | Forbes William P | Officer | A-Award | A | Stock Option (right to buy) | 137,500 | 0.51 | 70.3K | 137,500 | — | ↗ |
| 2022-02-11 | Delfini Lisa | Officer | A-Award | A | Stock Option (right to buy) | 110,000 | 0.51 | 56.2K | 110,000 | — | ↗ |
| 2022-01-12 | TPG GP A, LLC | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 4,824,883 | — | ↗ |
| 2021-10-18 | Walker Paul Edward | 10% Owner | P-Purchase | A | Common Stock | 1,851,852 | 1.62 | 3.00M | 7,789,850 | — | ↗ |
| 2021-10-18 | Sonsini Peter W. | 10% Owner | P-Purchase | A | Common Stock | 1,851,852 | 1.62 | 3.00M | 7,789,850 | — | ↗ |
| 2021-10-18 | SANDELL SCOTT D | 10% Owner | P-Purchase | A | Common Stock | 1,851,852 | 1.62 | 3.00M | 7,789,850 | — | ↗ |
| 2021-10-18 | New Enterprise Associates 16, L.P. | 10% Owner | P-Purchase | A | 3.5-Year Common Stock Warrant | 1,851,852 | 1.37 | 2.54M | 1,851,852 | — | ↗ |
| 2021-10-18 | Makhzoumi Mohamad | 10% Owner | P-Purchase | A | Common Stock | 1,851,852 | 1.62 | 3.00M | 7,789,850 | — | ↗ |
| 2021-10-18 | Florence Anthony A. Jr. | 10% Owner | P-Purchase | A | 7-Year Common Stock Warrant | 1,851,852 | 1.37 | 2.54M | 1,851,852 | — | ↗ |
| 2021-10-18 | Chang Carmen | 10% Owner | P-Purchase | A | 3.5-Year Common Stock Warrant | 1,851,852 | 1.37 | 2.54M | 1,851,852 | — | ↗ |
| 2021-10-18 | Behbahani Ali | 10% Owner | P-Purchase | A | 7-Year Common Stock Warrant | 1,851,852 | 1.37 | 2.54M | 1,851,852 | — | ↗ |
| 2021-10-18 | BASKETT FOREST | 10% Owner | P-Purchase | A | 7-Year Common Stock Warrant | 1,851,852 | 1.37 | 2.54M | 1,851,852 | — | ↗ |
| 2021-08-09 | Delfini Lisa | Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 1.97 | 197.0K | 100,000 | — | ↗ |
| 2021-06-16 | VANLENT ANNE | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 2.25 | 45.0K | 20,000 | — | ↗ |
| 2021-06-16 | Meeker David P | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 2.25 | 45.0K | 20,000 | — | ↗ |
| 2021-06-16 | Mathers Edward T | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 2.25 | 45.0K | 20,000 | — | ↗ |
| 2021-06-16 | Heffernan Michael Thomas | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 2.25 | 45.0K | 20,000 | — | ↗ |
| 2021-06-16 | Colangelo Dominick | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 2.25 | 45.0K | 20,000 | — | ↗ |
| 2021-06-16 | Cassella James V | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 2.25 | 45.0K | 20,000 | — | ↗ |
| 2021-04-13 | Galletta Christopher | Officer | A-Award | A | Stock Option (right to buy) | 25,000 | 2.53 | 63.3K | 25,000 | — | ↗ |
| 2021-04-12 | Galletta Christopher | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-02-17 | Seiter Christopher | Officer | A-Award | A | Stock Option (right to buy) | 80,000 | 3.21 | 256.8K | 80,000 | — | ↗ |
| 2021-02-17 | SCIASCIA THOMAS | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 3.21 | 160.5K | 50,000 | — | ↗ |
| 2021-02-17 | Muscolo Frank P | Officer | A-Award | A | Stock Option (right to buy) | 30,000 | 3.21 | 96.3K | 30,000 | — | ↗ |
| 2021-02-17 | GOOD JENNIFER L | Director / Officer | A-Award | A | Stock Option (right to buy) | 160,000 | 3.21 | 513.6K | 160,000 | — | ↗ |
| 2021-02-01 | Forbes William P | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-06-29 | Colangelo Dominick | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 23,684 | 6.87 | 162.7K | 23,684 | — | ↗ |
| 2020-06-11 | VANLENT ANNE | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 14,210 | 4.10 | 58.3K | 14,210 | — | ↗ |
| 2020-06-11 | Meeker David P | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 14,210 | 4.10 | 58.3K | 14,210 | — | ↗ |
| 2020-06-11 | Mathers Edward T | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 14,210 | 4.10 | 58.3K | 14,210 | — | ↗ |
| 2020-06-11 | Heffernan Michael Thomas | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 14,210 | 4.10 | 58.3K | 14,210 | — | ↗ |
| 2020-04-03 | Walker Paul Edward | 10% Owner | X-InTheMoney | A | Common Stock | 1,500,000 | 0.00 | 1.5K | 5,938,562 | — | ↗ |
| 2020-04-03 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Owner | X-InTheMoney | D | Call Option (obligation to sell) | 1 | 0.00 | — | 0 | — | ↗ |
| 2020-04-03 | Sonsini Peter W. | 10% Owner | X-InTheMoney | A | Common Stock | 1,500,000 | 0.00 | 1.5K | 5,938,562 | — | ↗ |
| 2020-04-03 | SANDELL SCOTT D | 10% Owner | S-Sale | D | Common Stock | 564 | 2.66 | 1.5K | 5,937,998 | — | ↗ |
| 2020-04-03 | New Enterprise Associates 16, L.P. | 10% Owner | X-InTheMoney | A | Common Stock | 1,500,000 | 0.00 | 1.5K | 5,938,562 | — | ↗ |
| 2020-04-03 | Makhzoumi Mohamad | 10% Owner | X-InTheMoney | D | Call Option (right to buy) | 1,500,000 | 0.00 | 1.5K | 0 | — | ↗ |
| 2020-04-03 | MAKOWER JOSHUA | 10% Owner | S-Sale | D | Common Stock | 564 | 2.66 | 1.5K | 5,937,998 | — | ↗ |
| 2020-04-03 | Florence Anthony A. Jr. | 10% Owner | S-Sale | D | Common Stock | 564 | 2.66 | 1.5K | 5,937,998 | — | ↗ |
| 2020-04-03 | Chang Carmen | 10% Owner | X-InTheMoney | A | Common Stock | 1,500,000 | 0.00 | 1.5K | 5,938,562 | — | ↗ |
| 2020-04-03 | Behbahani Ali | 10% Owner | S-Sale | D | Common Stock | 564 | 2.66 | 1.5K | 5,937,998 | — | ↗ |
| 2020-04-03 | BASKETT FOREST | 10% Owner | X-InTheMoney | A | Common Stock | 1,500,000 | 0.00 | 1.5K | 5,938,562 | — | ↗ |
| 2020-02-13 | Seiter Christopher | Officer | A-Award | A | Stock Option (right to buy) | 65,000 | 5.50 | 357.5K | 65,000 | — | ↗ |
| 2020-02-13 | SCIASCIA THOMAS | Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 5.50 | 330.0K | 60,000 | — | ↗ |
| 2020-02-13 | Muscolo Frank P | Officer | A-Award | A | Stock Option (right to buy) | 15,000 | 5.50 | 82.5K | 15,000 | — | ↗ |
| 2020-02-13 | Mazabraud Yann | Officer | A-Award | A | Stock Option (right to buy) | 70,000 | 5.50 | 385.0K | 70,000 | — | ↗ |
| 2020-02-13 | GOOD JENNIFER L | Director / Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 5.50 | 1.10M | 200,000 | — | ↗ |
| 2020-02-13 | Cassella James V | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-02-13 | Brett-Smith Helena | Officer | A-Award | A | Stock Option (right to buy) | 30,000 | 5.50 | 165.0K | 30,000 | — | ↗ |
| 2019-06-03 | Seiter Christopher | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 10.12 | 506.0K | 50,000 | — | ↗ |
| 2019-06-03 | SCIASCIA THOMAS | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 10.12 | 506.0K | 50,000 | — | ↗ |
| 2019-06-03 | Muscolo Frank P | Officer | A-Award | A | Stock Option (right to buy) | 15,000 | 10.12 | 151.8K | 15,000 | — | ↗ |
| 2019-06-03 | Mazabraud Yann | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 10.12 | 506.0K | 50,000 | — | ↗ |
| 2019-06-03 | GOOD JENNIFER L | Director / Officer | A-Award | A | Stock Option (right to buy) | 310,000 | 10.12 | 3.14M | 310,000 | — | ↗ |
| 2019-06-01 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Owner | X-InTheMoney | D | Common Stock | 200,000 | 0.00 | 200.00 | 6,324,319 | — | ↗ |
| 2019-05-09 | Walker Paul Edward | 10% Owner | C-Conversion | D | Series C Preferred Stock | 17,099,315 | 0.00 | — | 0 | — | ↗ |
| 2019-05-09 | VANLENT ANNE | Director | C-Conversion | D | Series C Preferred Stock | 47,807 | 0.00 | — | 0 | — | ↗ |
| 2019-05-09 | TPG Group Holdings (SBS) Advisors, Inc. | 10% Owner | C-Conversion | D | Series B Preferred Stock | 21,739,130 | 0.00 | — | 0 | — | ↗ |
| 2019-05-09 | Sonsini Peter W. | 10% Owner | P-Purchase | A | Common Stock | 1,000,000 | 10.00 | 10.00M | 2,938,562 | — | ↗ |
| 2019-05-09 | SCIASCIA THOMAS | Officer / 10% Owner | C-Conversion | D | Series C Preferred Stock | 13,410 | 0.00 | — | 0 | — | ↗ |
| 2019-05-09 | SANDELL SCOTT D | 10% Owner | C-Conversion | D | Series C Preferred Stock | 17,099,315 | 0.00 | — | 0 | — | ↗ |
| 2019-05-09 | Richard King Mellon Foundation | 10% Owner | C-Conversion | D | Series C Preferred Stock | 1,908,450 | 0.00 | — | 0 | — | ↗ |
| 2019-05-09 | Omega Fund V, L.P. | 10% Owner | C-Conversion | A | Common Stock | 582,408 | 0.00 | — | 582,408 | — | ↗ |
| 2019-05-09 | OSHEA WILLIAM J | 10% Owner | C-Conversion | D | Series A Preferred Stock | 307,607 | 0.00 | — | 0 | — | ↗ |
| 2019-05-09 | New Enterprise Associates 16, L.P. | 10% Owner | C-Conversion | A | Common Stock | 1,938,562 | 0.00 | — | 1,938,562 | — | ↗ |
| 2019-05-09 | Mellon Family Investment Co V | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 10.00 | 1.00M | 347,156 | — | ↗ |
| 2019-05-09 | Meeker David P | Director / 10% Owner | C-Conversion | D | Series A Preferred Stock | 95,712 | 0.00 | — | 0 | — | ↗ |
| 2019-05-09 | Makhzoumi Mohamad | 10% Owner | P-Purchase | A | Common Stock | 1,500,000 | 10.00 | 15.00M | 4,438,562 | — | ↗ |
Executive team
Top executives
Shares Outstanding
141.93M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Jennifer Good President and Chief Executive Officer | 622.4K | 343.8K | — | 2.97M | — | 10.5K | 3.94M | 75.24% | ↗ |
| 2 | 2025 | James Cassella, Ph.D. Chief Development Officer | 488.3K | 196.0K | — | 942.5K | — | 10.5K | 1.64M | 57.56% | ↗ |
| 3 | 2025 | Farrell Simon, Pharm. D. Chief Commercial Officer | 370.1K | 150.0K | — | 825.3K | — | 10.5K | 1.36M | 60.87% | ↗ |
| 4 | 2024 | Jennifer Good President and Chief Executive Officer | 607.9K | 369.0K | — | 1.60M | — | 10.4K | 2.59M | 61.87% | ↗ |
| 5 | 2024 | James Cassella, Ph.D. Chief Development Officer | 120.0K | 53.7K | — | 1.16M | — | 105.7K | 1.44M | 80.61% | ↗ |
| 6 | 2024 | Lisa Delfini Chief Financial Officer | 412.2K | 182.2K | — | 582.7K | — | 10.4K | 1.19M | 49.08% | ↗ |
| 7 | 2023 | Jennifer Good President and Chief Executive Officer | 596.9K | 229.1K | — | 851.4K | — | 9.9K | 1.69M | 50.46% | ↗ |
| 8 | 2023 | Thomas Sciascia, M.D. Chief Scientific Officer | 424.7K | 117.6K | — | 425.7K | — | 9.1K | 977.1K | 43.57% | ↗ |
| 9 | 2023 | David J. Clark, M.D., MBChB Chief Medical Officer | 479.0K | 131.6K | — | — | — | — | 610.6K | 0.00% | ↗ |
| 10 | 2022 | Jennifer Good President and Chief Executive Officer | 523.2K | 249.5K | — | 116.2K | — | 9.2K | 898.1K | 12.94% | ↗ |
| 11 | 2022 | David J. Clark, M.D., MBChB Chief Medical Officer | 54.2K | — | — | 526.6K | — | — | 580.8K | 90.66% | ↗ |
| 12 | 2022 | Thomas Sciascia, M.D. Chief Scientific Officer | 391.5K | 130.8K | — | 46.8K | — | 8.2K | 577.3K | 8.11% | ↗ |
| 13 | 2021 | Jennifer Good President and Chief Executive Officer | 506.0K | 216.8K | — | 796.0K | — | 8.7K | 1.53M | 52.12% | ↗ |
| 14 | 2021 | William Forbes, Pharm. D. Chief Development Officer | 406.7K | 153.0K | — | 621.1K | — | — | 1.18M | 52.60% | ↗ |
| 15 | 2021 | Thomas Sciascia, M.D. Chief Scientific Officer | 378.8K | 113.1K | — | 217.9K | — | 7.8K | 717.5K | 30.37% | ↗ |
| 16 | 2021 | Thomas Sciascia, M.D. Chief Medical Officer | 378.8K | 113.1K | — | 217.9K | — | 7.8K | 717.5K | 30.37% | ↗ |
| 17 | 2020 | Jennifer Good President and Chief Executive Officer | 477.7K | 176.4K | — | 778.8K | — | 8.6K | 1.44M | 54.03% | ↗ |
| 18 | 2020 | Yann Mazabraud Former Chief Commercial Officer and Head of International | 302.4K | — | — | 272.6K | — | 141.9K | 716.9K | 38.03% | ↗ |
| 19 | 2020 | Chris Seiter Former Chief Financial Officer | 357.1K | 99.3K | — | 253.1K | — | 6.7K | 716.2K | 35.34% | ↗ |
| 20 | 2020 | Thomas Sciascia, M.D. Chief Medical Officer | 368.6K | 99.7K | — | 233.6K | — | 7.9K | 709.9K | 32.91% | ↗ |
| 21 | 2020 | Thomas Sciascia Chief Medical Officer | 368.6K | 99.7K | — | 233.6K | — | 7.9K | 709.9K | 32.91% | ↗ |
| 22 | 2019 | Jennifer Good President and Chief Executive Officer | 434.6K | 144.9K | — | 2.22M | — | 8.4K | 2.81M | 79.08% | ↗ |
| 23 | 2019 | Yann Mazabraud Former Chief Commercial Officer and Head of International | 325.7K | 83.9K | — | 358.5K | — | 146.5K | 914.7K | 39.20% | ↗ |
| 24 | 2019 | Yann Mazabraud Chief Commercial Officer and Head of International | 325.7K | 83.9K | — | 358.5K | — | 146.5K | 914.7K | 39.20% | ↗ |
| 25 | 2019 | Thomas Sciascia Chief Medical Officer | 339.3K | 81.5K | — | 358.5K | — | 7.5K | 786.8K | 45.56% | ↗ |
| 26 | 2019 | Thomas Sciascia, M.D. Chief Medical Officer | 339.3K | 81.5K | — | 358.5K | — | 7.5K | 786.8K | 45.56% | ↗ |
| 27 | 2018 | Yann Mazabraud Chief Commercial Officer and Head of International | 185.3K | 35.2K | — | 571.2K | — | 221.2K | 1.01M | 56.39% | ↗ |
| 28 | 2018 | Jennifer Good President and Chief Executive Officer | 400.0K | 120.0K | — | — | — | 8.3K | 528.3K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jennifer L. Good | Co-Founder, Chief Executive Officer, President & Director | 976.6K | female |
| James V. Cassella | Chief Development Officer | 694.8K | — |
| Thomas R. Sciascia | Co-Founder & Chief Scientific Officer | 551.4K | — |
| Farrell Simon | Chief Commercial Officer | 530.6K | male |
| David C. Hastings | Chief Financial Officer & Principal Financial Officer | — | male |
| Katherine Takaki | Senior Vice President of Global Regulatory Affairs | — | female |
| Katie McManus | Communications Manager | — | — |
| Christopher Galletta | Controller & Chief Accounting Officer | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TRVI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
